Last reviewed · How we verify

NCT03767309

Management of Miller Class I & II Gingival Recession

Status unknown NA Last updated 17 January 2019
What this trial tests

NA trial testing coronally advanced flap with abrasive de-epithelized graft. in Gingival Recession in 20 participants. Status unknown.

Timeline
1 February 2019
Primary endpoint
1 January 2020
1 December 2020

Quick facts

Lead sponsorHalla Gamal Mohammed Esmail
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment20
Start date1 February 2019
Primary completion1 January 2020
Estimated completion1 December 2020

Drugs / interventions tested

Conditions studied

Sponsor

Halla Gamal Mohammed Esmail

Who can join

18 and older, any sex, with Gingival Recession. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Management of Miller class I \& II gingival recession using coronally advanced flap combined with conventional de-epithelialized free gingival graft versus coronally advanced flap combined with abrasive de-epithelized connective tissue graft Null hypothesis: In patients with Miller class I and II gingival recession, there is no difference between coronally advanced flap with conventional de-epithelialized free gingival graft and coronally advanced flap with abrasive de-epithelized connective tissue graft in recession depth reduction.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Gingival Recession

Currently open trials in the same condition.

Other Halla Gamal Mohammed Esmail trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03767309.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing